These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
768 related articles for article (PubMed ID: 18309090)
1. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats. You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090 [TBL] [Abstract][Full Text] [Related]
2. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs. Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525 [TBL] [Abstract][Full Text] [Related]
3. Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS Hypertension; 2008 Jun; 51(6):1537-44. PubMed ID: 18426993 [TBL] [Abstract][Full Text] [Related]
4. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats. Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats. Gao L; Yu DM Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171 [TBL] [Abstract][Full Text] [Related]
6. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Gosse P Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093 [TBL] [Abstract][Full Text] [Related]
7. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat. Gin T; Joon TL; Panagiotopoulos S; Cooper M; Taylor H; Jerums G Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):281-9. PubMed ID: 8603832 [TBL] [Abstract][Full Text] [Related]
8. Effect of estrogen on differentiation and senescence in endothelial progenitor cells derived from bone marrow in spontaneously hypertensive rats. Imanishi T; Kobayashi K; Hano T; Nishio I Hypertens Res; 2005 Sep; 28(9):763-72. PubMed ID: 16419650 [TBL] [Abstract][Full Text] [Related]
9. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. Fernandes T; Nakamuta JS; Magalhães FC; Roque FR; Lavini-Ramos C; Schettert IT; Coelho V; Krieger JE; Oliveira EM J Hypertens; 2012 Nov; 30(11):2133-43. PubMed ID: 23052048 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. de Nigris F; Balestrieri ML; Williams-Ignarro S; D'Armiento FP; Lerman LO; Byrns R; Crimi E; Palagiano A; Fatigati G; Ignarro LJ; Napoli C J Cardiovasc Pharmacol; 2007 Oct; 50(4):424-33. PubMed ID: 18049311 [TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME; Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199 [TBL] [Abstract][Full Text] [Related]
12. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension. de Leeuw PW; ; J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850 [TBL] [Abstract][Full Text] [Related]
14. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747 [TBL] [Abstract][Full Text] [Related]
15. Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment. Doucet J; Richard V; Mulder P; Henry JP; Schiavi P; Guez D; Thuillez C J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):107-11. PubMed ID: 11881108 [TBL] [Abstract][Full Text] [Related]
16. [Vascular impact of anti-hypertensive treatment and renal protection]. Mogensen CE Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence. Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A; J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849 [TBL] [Abstract][Full Text] [Related]
18. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527 [TBL] [Abstract][Full Text] [Related]
19. [Cardioprotective effects of anti-hypertensive medications]. Asmar RG Curr Med Res Opin; 2005; 21 Suppl 5():S17-21. PubMed ID: 16197648 [TBL] [Abstract][Full Text] [Related]
20. [Effects of perindopril and its combination with indapamide on risk stratification in patients with hypertension]. Ol'binskaia LI; Zheleznykh EA Ter Arkh; 2001; 73(9):22-4. PubMed ID: 11642074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]